Diabetes is one the most common diseases in the world, with an increasing number of patients being diagnosed. This is driving an increase in demand for treatments and other methods to control diabetes. This should provide enormous growth potential for diabetic stocks Medtronic (NYSE:) Insulet (NASDAQ :). What stock do you think is the best? Learn more. Medtronic plc, based in Ireland, sells medical devices to patients, doctors, clinicians, hospitals and other healthcare professionals around the world. It has four divisions: Cardiovascular Portfolio. Neuroscience Portfolio. Medical-Surgical portfolio. And Diabetes Operating unit. Insulet Corporation of Billerica, Mass. (PODD), develops and manufactures insulin delivery system for insulin-dependent diabetics.

Diabetes is the leading cause of death in the world. More than 10 percent of Americans have diabetes, according to studies. Recent research shows that type 1 and 2 diabetes cases are on the rise among American youth. Between 2001 and 2017, the number of type 1 diabetics under 20 years old increased by 45%. However, type 2 diabetes cases rose by 95%. Companies involved in the treatment of diabetes should see a growing market. Both PODD and MDT, two prominent players on the market, have the potential to reap the benefits.

PODD’s shares have gained 1.9% in price over the past six months, while MDT has returned 1.5%. In terms of their past year’s performance, PODD is the winner with 19.9% gains versus MDT’s 18.8%. Also, PODD’s 17.6% gains year-to-date compare with MDT’s 9.1% returns.

Continue reading on StockNews